Russell Swerdlow, M.D., is the Director of the University of Kansas Alzheimer's Disease Center and the KUMC Neurodegenerative Disorders Program. Dr. Swerdlow is a Professor in the Departments of Neurology, Molecular and Integrative Physiology, and Biochemistry and Molecular Biology at the University of Kansas School of Medicine. After receiving his undergraduate and doctor of medicine degrees from New York University, he trained as a neurologist and cognitive disorders subspecialist at the University of Virginia.
In addition to his clinical side, Dr. Swerdlow is a laboratory-based neuroscientist who is internationally known for his work on mitochondrial dysfunction in neurodegenerative diseases. National level recognition includes the S. Weir Mitchell Award from the American Academy of Neurology, a Cotzias Fellowship from the American Parkinson's Disease Association, research grants from the National Institutes of Health, and membership on NIH and Veteran's Administration Study Sections. Before joining KUMC in 2007, Dr. Swerdlow chaired the Alzheimer's Disease and Related Disorders Commission of the Commonwealth of Virginia, and from 2005-2010 he served as the Research Committee Chair for the CurePSP Foundation.
Dr. Swerdlow's laboratory is currently studying the interaction between genes and cell energy metabolism, the molecular consequences of altered cell energy metabolism, and strategies for repairing defective energy metabolism.
Please click here for a list of Dr. Swerdlow's recent publications.
Apr 03, 2013